SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $637,245 | -8.8% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $699,000 | -75.3% | 24,500 | -78.7% | 0.00% | -66.7% |
| Q2 2022 | $2,832,000 | +140.6% | 115,009 | +451.6% | 0.00% | +200.0% |
| Q1 2022 | $1,177,000 | -24.8% | 20,851 | -17.4% | 0.00% | 0.0% |
| Q4 2021 | $1,565,000 | -28.3% | 25,245 | -26.6% | 0.00% | -50.0% |
| Q3 2021 | $2,182,000 | -47.2% | 34,388 | -31.4% | 0.00% | -50.0% |
| Q2 2021 | $4,131,000 | +2.4% | 50,125 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $4,034,000 | +514.9% | 54,829 | +506.5% | 0.00% | +300.0% |
| Q4 2020 | $656,000 | – | 9,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |